Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seizure, Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06344338
What this trial is testing

Application of tDCS Stimulation in Controlling Refractory Status Epilepticus

Who this might be right for
Refractory Status Epilepticus
Xuanwu Hospital, Beijing 32
Not applicableStudy completedNCT03587506
What this trial is testing

Periodic Limb Movement and Genetic Generalized Epilepsy

Who this might be right for
Epilepsy Generalized Idiopathic Not Intractable
University of Alexandria 60
Testing effectiveness (Phase 2)Study completedNCT00175929
What this trial is testing

Brivaracetam in Subjects With Partial Onset Seizures

Who this might be right for
Epilepsy, Focal
UCB Pharma 157
Testing effectiveness (Phase 2)UnknownNCT03031028
What this trial is testing

Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.

Who this might be right for
Refractory Epilepsy
Tehran University of Medical Sciences 30
Not applicableLooking for participantsNCT05469373
What this trial is testing

ESIS in Pediatric DRE

Who this might be right for
Epilepsy
Sarah Katie Ihnen 86
Large-scale testing (Phase 3)Ended earlyNCT00372528
What this trial is testing

An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures

Who this might be right for
Epilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05339126
What this trial is testing

RNS System LGS Feasibility Study

Who this might be right for
EpilepsyLennox Gastaut SyndromeLennox-Gastaut Syndrome, Intractable+2 more
NeuroPace 24
Not applicableStudy completedNCT00001666
What this trial is testing

Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy

Who this might be right for
Partial EpilepsySeizures
National Institute of Neurological Disorders and Stroke (NINDS) 32
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Not applicableStudy completedNCT02497105
What this trial is testing

Ketogenic Diet Program for Epilepsy

Who this might be right for
Epilepsy
Shriners Hospitals for Children 30
Testing effectiveness (Phase 2)Study completedNCT02920060
What this trial is testing

Levetiracetam Versus Sodium Valproate in Children With Refractory Generalized Convulsive Status Epilepticus

Who this might be right for
Grand Mal Status Epilepticus
Banaras Hindu University 80
Testing effectiveness (Phase 2)UnknownNCT03356769
What this trial is testing

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Who this might be right for
Tuberous Sclerosis ComplexAspirinEpilepsy+2 more
Peking Union Medical College Hospital 98
Large-scale testing (Phase 3)Study completedNCT00334958
What this trial is testing

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Inc. 356
Large-scale testing (Phase 3)Active Not RecruitingNCT02962414
What this trial is testing

Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment

Who this might be right for
Tuberous Sclerosis Complex
Novartis Pharmaceuticals 206
Post-approval studies (Phase 4)UnknownNCT04705298
What this trial is testing

Role of the Gut Microbiota in Pediatric Epilepsy

Who this might be right for
Drug Resistant Epilepsy
British Columbia Children's Hospital 45
Large-scale testing (Phase 3)Study completedNCT00957047
What this trial is testing

Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 395
Large-scale testing (Phase 3)WithdrawnNCT00422110
What this trial is testing

Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures

Who this might be right for
Epilepsies, Partial
UCB Pharma
Not applicableUnknownNCT01533649
What this trial is testing

Personalizing Health Outcome in Epilepsy Now - An Introduction to Clinical Services

Who this might be right for
Medically Intractable Epilepsy
University Health Network, Toronto 30
Not applicableActive Not RecruitingNCT07100743
What this trial is testing

Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE)

Who this might be right for
Epilepsies Refractory
National University of Malaysia 78
Not applicableNot Yet RecruitingNCT06581133
What this trial is testing

Sleep Disruption Pattern - Epilepsy Monitoring Unit

Who this might be right for
Epilepsy Intractable
Duke University 75
Next Page